JP2015504095A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015504095A5 JP2015504095A5 JP2014553491A JP2014553491A JP2015504095A5 JP 2015504095 A5 JP2015504095 A5 JP 2015504095A5 JP 2014553491 A JP2014553491 A JP 2014553491A JP 2014553491 A JP2014553491 A JP 2014553491A JP 2015504095 A5 JP2015504095 A5 JP 2015504095A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- tetrazol
- difluorophenyl
- alkyl
- pyridin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 36
- 125000000217 alkyl group Chemical group 0.000 claims 23
- 150000001875 compounds Chemical class 0.000 claims 22
- 201000010099 disease Diseases 0.000 claims 20
- 238000000034 method Methods 0.000 claims 19
- 125000001188 haloalkyl group Chemical group 0.000 claims 14
- 208000035475 disorder Diseases 0.000 claims 13
- 125000005843 halogen group Chemical group 0.000 claims 13
- 125000000753 cycloalkyl group Chemical group 0.000 claims 12
- 210000003169 central nervous system Anatomy 0.000 claims 8
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 8
- 239000003795 chemical substances by application Substances 0.000 claims 7
- -1 1H-tetrazol-1-yl Chemical group 0.000 claims 6
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims 6
- 125000004438 haloalkoxy group Chemical group 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 6
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 5
- 241000222122 Candida albicans Species 0.000 claims 4
- 201000007336 Cryptococcosis Diseases 0.000 claims 4
- 241000221204 Cryptococcus neoformans Species 0.000 claims 4
- 206010017533 Fungal infection Diseases 0.000 claims 4
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 claims 4
- 241000223230 Trichosporon Species 0.000 claims 4
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 4
- 125000003118 aryl group Chemical group 0.000 claims 4
- 125000005160 aryl oxy alkyl group Chemical group 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 125000001153 fluoro group Chemical group F* 0.000 claims 4
- 125000004994 halo alkoxy alkyl group Chemical group 0.000 claims 4
- 125000001072 heteroaryl group Chemical group 0.000 claims 4
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 claims 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 4
- 208000030159 metabolic disease Diseases 0.000 claims 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 4
- 125000003226 pyrazolyl group Chemical group 0.000 claims 4
- 125000003831 tetrazolyl group Chemical group 0.000 claims 4
- 229940124597 therapeutic agent Drugs 0.000 claims 4
- 125000004001 thioalkyl group Chemical group 0.000 claims 4
- 125000001425 triazolyl group Chemical group 0.000 claims 4
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 claims 3
- 208000018522 Gastrointestinal disease Diseases 0.000 claims 3
- 229940127089 cytotoxic agent Drugs 0.000 claims 3
- 208000010643 digestive system disease Diseases 0.000 claims 3
- 208000018685 gastrointestinal system disease Diseases 0.000 claims 3
- 208000015181 infectious disease Diseases 0.000 claims 3
- 201000000317 pneumocystosis Diseases 0.000 claims 3
- 208000014001 urinary system disease Diseases 0.000 claims 3
- IEYCWUALSWPHDI-UHFFFAOYSA-N 1-[4-[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(tetrazol-1-yl)propyl]pyridin-3-yl]phenyl]-2,2,2-trifluoroethanone Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=CC(=CC=1)C=1C=CC(=CC=1)C(=O)C(F)(F)F)(O)CN1C=NN=N1 IEYCWUALSWPHDI-UHFFFAOYSA-N 0.000 claims 2
- QFSIEMVDJIQESH-UHFFFAOYSA-N 1-[5-(4-chloro-3-fluorophenyl)pyridin-2-yl]-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=CC(=CC=1)C=1C=C(F)C(Cl)=CC=1)(O)CN1C=NN=N1 QFSIEMVDJIQESH-UHFFFAOYSA-N 0.000 claims 2
- LTGBNLMVVAFZGT-UHFFFAOYSA-N 1-[5-[4-(difluoromethoxy)phenyl]pyridin-2-yl]-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=CC(=CC=1)C=1C=CC(OC(F)F)=CC=1)(O)CN1C=NN=N1 LTGBNLMVVAFZGT-UHFFFAOYSA-N 0.000 claims 2
- GSIBKGBPHNSCOU-UHFFFAOYSA-N 1-[5-[4-(difluoromethylsulfanyl)phenyl]pyridin-2-yl]-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=CC(=CC=1)C=1C=CC(SC(F)F)=CC=1)(O)CN1C=NN=N1 GSIBKGBPHNSCOU-UHFFFAOYSA-N 0.000 claims 2
- BLPPSIFFRCQAID-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-phenylpyridin-2-yl)-3-(tetrazol-1-yl)propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=CC(=CC=1)C=1C=CC=CC=1)(O)CN1C=NN=N1 BLPPSIFFRCQAID-UHFFFAOYSA-N 0.000 claims 2
- YQTJCWNNHNJRAY-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-1-[5-[4-[(2-methylpropan-2-yl)oxy]phenyl]pyridin-2-yl]-3-(tetrazol-1-yl)propan-2-ol Chemical compound C1=CC(OC(C)(C)C)=CC=C1C1=CC=C(C(F)(F)C(O)(CN2N=NN=C2)C=2C(=CC(F)=CC=2)F)N=C1 YQTJCWNNHNJRAY-UHFFFAOYSA-N 0.000 claims 2
- CAXYCUMJWGYZCQ-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)-1-[5-[3-(trifluoromethyl)phenyl]pyridin-2-yl]propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=CC(=CC=1)C=1C=C(C=CC=1)C(F)(F)F)(O)CN1C=NN=N1 CAXYCUMJWGYZCQ-UHFFFAOYSA-N 0.000 claims 2
- NGSZMSSFJMJEPD-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)-1-[5-[4-(2,2,2-trifluoroethyl)phenyl]pyridin-2-yl]propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=CC(=CC=1)C=1C=CC(CC(F)(F)F)=CC=1)(O)CN1C=NN=N1 NGSZMSSFJMJEPD-UHFFFAOYSA-N 0.000 claims 2
- IBQKNYMGTNJJGD-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)-1-[5-[4-(2,2,2-trifluoroethylsulfanyl)phenyl]pyridin-2-yl]propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=CC(=CC=1)C=1C=CC(SCC(F)(F)F)=CC=1)(O)CN1C=NN=N1 IBQKNYMGTNJJGD-UHFFFAOYSA-N 0.000 claims 2
- JBDKQTLQCWIBHU-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)-1-[5-[4-(3,3,3-trifluoropropoxy)phenyl]pyridin-2-yl]propan-2-ol Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=CC(=CC=1)C=1C=CC(OCCC(F)(F)F)=CC=1)(O)CN1C=NN=N1 JBDKQTLQCWIBHU-UHFFFAOYSA-N 0.000 claims 2
- QBUDANSQCYSGLX-UHFFFAOYSA-N 2-(4-chloro-2-fluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)-1-[5-[4-(trifluoromethoxy)phenyl]pyridin-2-yl]propan-2-ol Chemical compound C=1C=C(Cl)C=C(F)C=1C(C(F)(F)C=1N=CC(=CC=1)C=1C=CC(OC(F)(F)F)=CC=1)(O)CN1C=NN=N1 QBUDANSQCYSGLX-UHFFFAOYSA-N 0.000 claims 2
- PDUNABKLLIZVMV-UHFFFAOYSA-N 3-[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(tetrazol-1-yl)propyl]pyridin-3-yl]phenol Chemical compound OC1=CC=CC(C=2C=NC(=CC=2)C(F)(F)C(O)(CN2N=NN=C2)C=2C(=CC(F)=CC=2)F)=C1 PDUNABKLLIZVMV-UHFFFAOYSA-N 0.000 claims 2
- 201000002909 Aspergillosis Diseases 0.000 claims 2
- 208000036641 Aspergillus infections Diseases 0.000 claims 2
- 241000228245 Aspergillus niger Species 0.000 claims 2
- 206010007134 Candida infections Diseases 0.000 claims 2
- 241000222178 Candida tropicalis Species 0.000 claims 2
- 208000024172 Cardiovascular disease Diseases 0.000 claims 2
- 241000223203 Coccidioides Species 0.000 claims 2
- 241000223205 Coccidioides immitis Species 0.000 claims 2
- 208000035473 Communicable disease Diseases 0.000 claims 2
- 241001634927 Cutaneotrichosporon mucoides Species 0.000 claims 2
- 206010012504 Dermatophytosis Diseases 0.000 claims 2
- 241000427940 Fusarium solani Species 0.000 claims 2
- 244000286779 Hansenula anomala Species 0.000 claims 2
- 235000014683 Hansenula anomala Nutrition 0.000 claims 2
- 241000228402 Histoplasma Species 0.000 claims 2
- 201000002563 Histoplasmosis Diseases 0.000 claims 2
- 241000893980 Microsporum canis Species 0.000 claims 2
- 241001460074 Microsporum distortum Species 0.000 claims 2
- 208000031888 Mycoses Diseases 0.000 claims 2
- 241000893974 Nannizzia fulva Species 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 208000010195 Onychomycosis Diseases 0.000 claims 2
- 206010033767 Paracoccidioides infections Diseases 0.000 claims 2
- 201000000301 Paracoccidioidomycosis Diseases 0.000 claims 2
- 241000228143 Penicillium Species 0.000 claims 2
- 241000235648 Pichia Species 0.000 claims 2
- 208000005384 Pneumocystis Pneumonia Diseases 0.000 claims 2
- 206010073755 Pneumocystis jirovecii pneumonia Diseases 0.000 claims 2
- 208000004364 Rhinosporidiosis Diseases 0.000 claims 2
- 241000223254 Rhodotorula mucilaginosa Species 0.000 claims 2
- 208000002474 Tinea Diseases 0.000 claims 2
- 206010056131 Tinea versicolour Diseases 0.000 claims 2
- 241000223238 Trichophyton Species 0.000 claims 2
- 241001045770 Trichophyton mentagrophytes Species 0.000 claims 2
- 241000223229 Trichophyton rubrum Species 0.000 claims 2
- 241001480050 Trichophyton violaceum Species 0.000 claims 2
- 241001634942 Trichosporon inkin Species 0.000 claims 2
- 208000012931 Urologic disease Diseases 0.000 claims 2
- 206010061418 Zygomycosis Diseases 0.000 claims 2
- 241000222126 [Candida] glabrata Species 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 239000002260 anti-inflammatory agent Substances 0.000 claims 2
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 2
- 230000001028 anti-proliverative effect Effects 0.000 claims 2
- 239000003429 antifungal agent Substances 0.000 claims 2
- 229940121375 antifungal agent Drugs 0.000 claims 2
- 239000002246 antineoplastic agent Substances 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 229940095731 candida albicans Drugs 0.000 claims 2
- 208000032343 candida glabrata infection Diseases 0.000 claims 2
- 201000003984 candidiasis Diseases 0.000 claims 2
- 239000002327 cardiovascular agent Substances 0.000 claims 2
- 229940125692 cardiovascular agent Drugs 0.000 claims 2
- 201000003486 coccidioidomycosis Diseases 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 239000002254 cytotoxic agent Substances 0.000 claims 2
- 231100000599 cytotoxic agent Toxicity 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 208000030172 endocrine system disease Diseases 0.000 claims 2
- HZLNQXPXQPWTKY-UHFFFAOYSA-N ethyl 2-[4-[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(tetrazol-1-yl)propyl]pyridin-3-yl]phenoxy]-2,2-difluoroacetate Chemical compound C1=CC(OC(F)(F)C(=O)OCC)=CC=C1C1=CC=C(C(F)(F)C(O)(CN2N=NN=C2)C=2C(=CC(F)=CC=2)F)N=C1 HZLNQXPXQPWTKY-UHFFFAOYSA-N 0.000 claims 2
- 208000024386 fungal infectious disease Diseases 0.000 claims 2
- 244000053095 fungal pathogen Species 0.000 claims 2
- 208000027866 inflammatory disease Diseases 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 201000007524 mucormycosis Diseases 0.000 claims 2
- ZLJNVYHHBJHWCQ-UHFFFAOYSA-N n-[4-[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(tetrazol-1-yl)propyl]pyridin-3-yl]phenyl]-2,2,2-trifluoroacetamide Chemical compound C=1C=C(F)C=C(F)C=1C(C(F)(F)C=1N=CC(=CC=1)C=1C=CC(NC(=O)C(F)(F)F)=CC=1)(O)CN1C=NN=N1 ZLJNVYHHBJHWCQ-UHFFFAOYSA-N 0.000 claims 2
- 241000894007 species Species 0.000 claims 2
- 230000009885 systemic effect Effects 0.000 claims 2
- IMCGHZIGRANKHV-AJNGGQMLSA-N tert-butyl (3s,5s)-2-oxo-5-[(2s,4s)-5-oxo-4-propan-2-yloxolan-2-yl]-3-propan-2-ylpyrrolidine-1-carboxylate Chemical compound O1C(=O)[C@H](C(C)C)C[C@H]1[C@H]1N(C(=O)OC(C)(C)C)C(=O)[C@H](C(C)C)C1 IMCGHZIGRANKHV-AJNGGQMLSA-N 0.000 claims 2
- 201000005882 tinea unguium Diseases 0.000 claims 2
- 230000002485 urinary effect Effects 0.000 claims 2
- FMHFVGODKSOEKV-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-3-fluoro-1-(tetrazol-1-yl)-3-[5-[4-(2,2,2-trifluoroethoxy)phenyl]pyridin-2-yl]butan-2-ol Chemical compound C1=NN=NN1CC(O)(C=1C(=CC(F)=CC=1)F)C(F)(C)C(N=C1)=CC=C1C1=CC=C(OCC(F)(F)F)C=C1 FMHFVGODKSOEKV-UHFFFAOYSA-N 0.000 claims 1
- HSUXUELXFIFBIT-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-3-fluoro-1-(tetrazol-1-yl)-3-[5-[4-(trifluoromethoxy)phenyl]pyridin-2-yl]butan-2-ol Chemical compound C1=NN=NN1CC(O)(C=1C(=CC(F)=CC=1)F)C(F)(C)C(N=C1)=CC=C1C1=CC=C(OC(F)(F)F)C=C1 HSUXUELXFIFBIT-UHFFFAOYSA-N 0.000 claims 1
- JVHZFKDSOUQLNB-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-3-fluoro-1-(tetrazol-1-yl)-3-[5-[4-(trifluoromethyl)phenyl]pyridin-2-yl]butan-2-ol Chemical compound C1=NN=NN1CC(O)(C=1C(=CC(F)=CC=1)F)C(F)(C)C(N=C1)=CC=C1C1=CC=C(C(F)(F)F)C=C1 JVHZFKDSOUQLNB-UHFFFAOYSA-N 0.000 claims 1
- XAFSRHUAOWTMSL-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-3-fluoro-3-[5-(4-fluorophenyl)pyridin-2-yl]-1-(tetrazol-1-yl)butan-2-ol Chemical compound C1=NN=NN1CC(O)(C=1C(=CC(F)=CC=1)F)C(F)(C)C(N=C1)=CC=C1C1=CC=C(F)C=C1 XAFSRHUAOWTMSL-UHFFFAOYSA-N 0.000 claims 1
- KYMREFHKHDOGRO-UHFFFAOYSA-N 2-(2,4-difluorophenyl)-3-fluoro-3-[5-(4-fluorophenyl)pyridin-2-yl]-1-(tetrazol-2-yl)butan-2-ol Chemical compound N1=CN=NN1CC(O)(C=1C(=CC(F)=CC=1)F)C(F)(C)C(N=C1)=CC=C1C1=CC=C(F)C=C1 KYMREFHKHDOGRO-UHFFFAOYSA-N 0.000 claims 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- PQEHIYKEYOVAFU-UHFFFAOYSA-N 3-[5-(4-chlorophenyl)pyridin-2-yl]-2-(2,4-difluorophenyl)-3-fluoro-1-(tetrazol-1-yl)butan-2-ol Chemical compound C1=NN=NN1CC(O)(C=1C(=CC(F)=CC=1)F)C(F)(C)C(N=C1)=CC=C1C1=CC=C(Cl)C=C1 PQEHIYKEYOVAFU-UHFFFAOYSA-N 0.000 claims 1
- 241000235389 Absidia Species 0.000 claims 1
- 241000228212 Aspergillus Species 0.000 claims 1
- 241001225321 Aspergillus fumigatus Species 0.000 claims 1
- 241000228405 Blastomyces dermatitidis Species 0.000 claims 1
- 241000222173 Candida parapsilosis Species 0.000 claims 1
- 241000233001 Carios Species 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- 206010008803 Chromoblastomycosis Diseases 0.000 claims 1
- 208000015116 Chromomycosis Diseases 0.000 claims 1
- 241000543381 Cliftonia monophylla Species 0.000 claims 1
- 208000017701 Endocrine disease Diseases 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- LFVLUOAHQIVABZ-UHFFFAOYSA-N Iodofenphos Chemical compound COP(=S)(OC)OC1=CC(Cl)=C(I)C=C1Cl LFVLUOAHQIVABZ-UHFFFAOYSA-N 0.000 claims 1
- 241000235645 Pichia kudriavzevii Species 0.000 claims 1
- 241000233870 Pneumocystis Species 0.000 claims 1
- 241000233872 Pneumocystis carinii Species 0.000 claims 1
- 241000235527 Rhizopus Species 0.000 claims 1
- 240000005384 Rhizopus oryzae Species 0.000 claims 1
- 235000013752 Rhizopus oryzae Nutrition 0.000 claims 1
- 241000222481 Schizophyllum commune Species 0.000 claims 1
- 239000004037 angiogenesis inhibitor Substances 0.000 claims 1
- 230000001772 anti-angiogenic effect Effects 0.000 claims 1
- 230000001093 anti-cancer Effects 0.000 claims 1
- 229940091771 aspergillus fumigatus Drugs 0.000 claims 1
- 229940055022 candida parapsilosis Drugs 0.000 claims 1
- 230000029087 digestion Effects 0.000 claims 1
- 208000016097 disease of metabolism Diseases 0.000 claims 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- QPPQHRDVPBTVEV-UHFFFAOYSA-N isopropyl dihydrogen phosphate Chemical compound CC(C)OP(O)(O)=O QPPQHRDVPBTVEV-UHFFFAOYSA-N 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 238000007665 sagging Methods 0.000 claims 1
- 235000021419 vinegar Nutrition 0.000 claims 1
- 239000000052 vinegar Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261589076P | 2012-01-20 | 2012-01-20 | |
| US61/589,076 | 2012-01-20 | ||
| PCT/US2013/022313 WO2013109998A1 (en) | 2012-01-20 | 2013-01-18 | Metalloenzyme inhibitor compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015504095A JP2015504095A (ja) | 2015-02-05 |
| JP2015504095A5 true JP2015504095A5 (enExample) | 2016-03-03 |
| JP6189865B2 JP6189865B2 (ja) | 2017-08-30 |
Family
ID=48799718
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014553491A Active JP6189865B2 (ja) | 2012-01-20 | 2013-01-18 | 金属酵素阻害薬化合物 |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US10221160B2 (enExample) |
| EP (1) | EP2804858B1 (enExample) |
| JP (1) | JP6189865B2 (enExample) |
| KR (1) | KR102061137B1 (enExample) |
| CN (1) | CN104136427B (enExample) |
| AU (2) | AU2013209516A1 (enExample) |
| BR (1) | BR112014017751B1 (enExample) |
| CA (1) | CA2861339C (enExample) |
| DK (1) | DK2804858T3 (enExample) |
| EA (1) | EA026209B1 (enExample) |
| ES (1) | ES2774267T3 (enExample) |
| IN (1) | IN2014DN06792A (enExample) |
| PL (1) | PL2804858T3 (enExample) |
| WO (1) | WO2013109998A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6159318B2 (ja) | 2011-06-19 | 2017-07-05 | ヴィアメット ファーマスーティカルズ，インコーポレイテッド | 金属酵素阻害化合物 |
| EA026209B1 (ru) * | 2012-01-20 | 2017-03-31 | Ваймет Фармасьютикалс, Инк. | Соединения, ингибирующие металлоферменты |
| EP3119771B1 (en) * | 2014-03-19 | 2020-05-06 | Mycovia Pharmaceuticals, Inc. | Antifungal compound process |
| US10399943B2 (en) | 2014-03-19 | 2019-09-03 | Mycovia Pharmaceuticals, Inc. | Antifungal compound process |
| MX365494B (es) * | 2014-03-19 | 2019-06-05 | Us Health | Procedimiento de compuesto antifungico. |
| WO2015143192A1 (en) | 2014-03-19 | 2015-09-24 | Viamet Pharmaceuticals, Inc. | 2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-substituted-pyridin-2-yl)-3-(1h-tetrazol-1-yl)propan-2-ols and processes for their preparation |
| EP3119749A4 (en) * | 2014-03-19 | 2017-12-13 | Viamet Pharmaceuticals, Inc. | Antifungal compound process |
| AU2015231275B2 (en) * | 2014-03-19 | 2019-03-07 | Mycovia Pharmaceuticals, Inc. | Antifungal compound process |
| JP2017509646A (ja) | 2014-03-19 | 2017-04-06 | ヴィアメット ファーマスーティカルズ，インコーポレイテッド | 抗真菌化合物の調製方法 |
| JP6572234B2 (ja) * | 2014-03-19 | 2019-09-04 | ヴィアメット ファーマスーティカルズ（エヌシー），インコーポレイテッド | 抗真菌化合物の調製方法 |
| BR112016021257B1 (pt) | 2014-03-19 | 2021-03-02 | Viamet Pharmaceuticals (NC), Inc. | 2-(2,4- difluorofenil-1,1-diflúor-1-(5-substituído-piridin-2-il)-3- (1h-tetrazol-1-il)propan-2-óis e processos para preparação e uso dos mesmos |
| JP2017514790A (ja) * | 2014-03-19 | 2017-06-08 | ヴィアメット ファーマスーティカルズ，インコーポレイテッド | 抗真菌化合物の調製方法 |
| EA037556B1 (ru) | 2015-03-19 | 2021-04-14 | Майковиа Фармасьютикалс, Инк. | Полиморфные формы противогрибковых соединений и способы их получения |
| US10513505B2 (en) | 2015-09-18 | 2019-12-24 | Nqp 1598, Ltd. | Antifungal compound process |
| US10464922B2 (en) | 2015-12-30 | 2019-11-05 | Nqp 1598, Ltd. | Metalloenzyme inhibitor compounds |
| ES2970715T3 (es) | 2016-12-22 | 2024-05-30 | Prec Pharmaceuticals Inc | Composiciones y métodos para inhibir la actividad de la arginasa |
| CN109666019B (zh) * | 2017-10-14 | 2021-04-06 | 朱允涛 | 一种氘代的氮唑醇类化合物及其制备方法和用途 |
| CN109810049B (zh) * | 2018-11-30 | 2021-01-15 | 深圳大学 | 一种含吡啶的化合物及其提取方法 |
| WO2021143811A1 (zh) * | 2020-01-17 | 2021-07-22 | 上海森辉医药有限公司 | 四氮唑类化合物的可药用盐及其结晶形式、制备方法和用途 |
| AU2021361997A1 (en) * | 2020-10-16 | 2023-06-15 | Miralogx Llc | Metalloenzyme inhibitors for treating cancers, alzheimer's disease, hemochromatosis, and other disorders |
Family Cites Families (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8304282D0 (en) * | 1983-02-16 | 1983-03-23 | Pfizer Ltd | Antifungal agents |
| GB8305377D0 (en) | 1983-02-25 | 1983-03-30 | Pfizer Ltd | Antifungal agents |
| US4921475A (en) | 1983-08-18 | 1990-05-01 | Drug Delivery Systems Inc. | Transdermal drug patch with microtubes |
| US5087240A (en) | 1983-08-18 | 1992-02-11 | Drug Delivery Systems Inc. | Transdermal drug patch with conductive fibers |
| AU4327585A (en) | 1984-06-21 | 1986-01-02 | Imperial Chemical Industries Plc | Antifungal azole compounds |
| GB8415889D0 (en) | 1984-06-21 | 1984-07-25 | Ici Plc | Antifungal azole compounds |
| US4738851A (en) | 1985-09-27 | 1988-04-19 | University Of Iowa Research Foundation, Inc. | Controlled release ophthalmic gel formulation |
| US5163899A (en) | 1987-03-20 | 1992-11-17 | Drug Delivery Systems Inc. | Transdermal drug delivery system |
| US5312325A (en) | 1987-05-28 | 1994-05-17 | Drug Delivery Systems Inc | Pulsating transdermal drug delivery system |
| GB8804164D0 (en) | 1988-02-23 | 1988-03-23 | Tucker J M | Bandage for administering physiologically active compound |
| US4882150A (en) | 1988-06-03 | 1989-11-21 | Kaufman Herbert E | Drug delivery system |
| US5008110A (en) | 1988-11-10 | 1991-04-16 | The Procter & Gamble Company | Storage-stable transdermal patch |
| US5088977A (en) | 1988-12-21 | 1992-02-18 | Drug Delivery Systems Inc. | Electrical transdermal drug applicator with counteractor and method of drug delivery |
| US5521222A (en) | 1989-09-28 | 1996-05-28 | Alcon Laboratories, Inc. | Topical ophthalmic pharmaceutical vehicles |
| DE69009946T2 (de) | 1989-12-04 | 1994-11-03 | Searle & Co | System zur transdermalen Albuterol Applikation. |
| US5077033A (en) | 1990-08-07 | 1991-12-31 | Mediventures Inc. | Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide |
| JP2594486B2 (ja) | 1991-01-15 | 1997-03-26 | アルコン ラボラトリーズ インコーポレイテッド | 局所的眼薬組成物 |
| US5352456A (en) | 1991-10-10 | 1994-10-04 | Cygnus Therapeutic Systems | Device for administering drug transdermally which provides an initial pulse of drug |
| GB9121456D0 (en) * | 1991-10-10 | 1991-11-27 | Pfizer Ltd | Triazole antifungal agents |
| JPH07502219A (ja) | 1991-12-18 | 1995-03-09 | ミネソタ マイニング アンド マニュファクチャリング カンパニー | 多重層型バリアー構造体 |
| ATE132381T1 (de) | 1992-01-29 | 1996-01-15 | Voelkl Franz Ski | Ballspielschläger, insbesondere tennisschläger |
| US5358939A (en) | 1992-06-25 | 1994-10-25 | Rohm And Haas Company | Fungicidal 2-aryl-2,2-disubstituted ethyl-1,2,4-triazoles |
| IL114193A (en) | 1994-06-20 | 2000-02-29 | Teva Pharma | Ophthalmic pharmaceutical compositions based on sodium alginate |
| ES2094688B1 (es) | 1994-08-08 | 1997-08-01 | Cusi Lab | Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion. |
| MY115814A (en) | 1995-06-16 | 2003-09-30 | Bayer Ip Gmbh | Crop protection compositions |
| GB9512961D0 (en) | 1995-06-26 | 1995-08-30 | Pfizer Ltd | Antifungal agents |
| GB9602080D0 (en) | 1996-02-02 | 1996-04-03 | Pfizer Ltd | Pharmaceutical compounds |
| IT1283911B1 (it) | 1996-02-05 | 1998-05-07 | Farmigea Spa | Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo |
| US5800807A (en) | 1997-01-29 | 1998-09-01 | Bausch & Lomb Incorporated | Ophthalmic compositions including glycerin and propylene glycol |
| US6261547B1 (en) | 1998-04-07 | 2001-07-17 | Alcon Manufacturing, Ltd. | Gelling ophthalmic compositions containing xanthan gum |
| US6197934B1 (en) | 1998-05-22 | 2001-03-06 | Collagenesis, Inc. | Compound delivery using rapidly dissolving collagen film |
| JP2000344744A (ja) * | 1999-06-04 | 2000-12-12 | Ss Pharmaceut Co Ltd | アセトフェノン誘導体およびその製法 |
| US6362172B2 (en) | 2000-01-20 | 2002-03-26 | Bristol-Myers Squibb Company | Water soluble prodrugs of azole compounds |
| EP2073741A4 (en) | 2006-10-18 | 2013-07-24 | Bnl Biotech Co Ltd | ENDODONTIC INSTRUMENT FOR SHUTDOWN OF RADICULAR CHANNEL AND HEATED END SUITABLE FOR THIS INSTRUMENT |
| US8680270B2 (en) | 2006-11-21 | 2014-03-25 | Viamet Pharmaceuticals, Inc. | Metallo-oxidoreductase inhibitors using metal binding moieties in combination with targeting moieties |
| US8221057B2 (en) | 2008-06-25 | 2012-07-17 | General Electric Company | Method, system and controller for establishing a wheel space temperature alarm in a turbomachine |
| KR20110048586A (ko) | 2008-09-03 | 2011-05-11 | 바이엘 크롭사이언스 아게 | 특정 녹병균을 구제하기 위한 살진균성 조성물의 용도 |
| EP2519508B1 (en) * | 2009-12-31 | 2014-07-02 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
| DK2563771T3 (en) * | 2010-04-24 | 2016-02-29 | Viamet Pharmaceuticals Inc | Metalloenzyminhibitorforbindelser |
| WO2012058529A2 (en) * | 2010-10-28 | 2012-05-03 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
| CN103339115B (zh) * | 2010-11-13 | 2016-08-31 | 茵库恩制药有限公司 | 金属酶抑制剂化合物 |
| EA201390876A1 (ru) * | 2010-12-13 | 2013-12-30 | Вайамет Фармасьютикалс, Инк. | Соединения, ингибирующие металлоферменты |
| JP6159318B2 (ja) * | 2011-06-19 | 2017-07-05 | ヴィアメット ファーマスーティカルズ，インコーポレイテッド | 金属酵素阻害化合物 |
| EP3067350B1 (en) * | 2011-06-19 | 2018-06-13 | Viamet Pharmaceuticals (NC), Inc. | Metalloenzyme inhibitor compounds |
| WO2012177728A1 (en) * | 2011-06-23 | 2012-12-27 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
| EP2751117A4 (en) * | 2011-08-30 | 2015-06-24 | Innocrin Pharmaceuticals Inc | METALLOENZYMHEMMERVERBINDUNGEN |
| SI2788343T1 (sl) * | 2011-12-11 | 2019-09-30 | Viamet Pharmaceuticals (NC), Inc. | Spojine inhibitorja metaloencimov |
| US9414596B2 (en) | 2012-01-20 | 2016-08-16 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
| EA026209B1 (ru) * | 2012-01-20 | 2017-03-31 | Ваймет Фармасьютикалс, Инк. | Соединения, ингибирующие металлоферменты |
| WO2014117090A1 (en) * | 2013-01-28 | 2014-07-31 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
| KR20160018811A (ko) * | 2013-06-12 | 2016-02-17 | 비아멧 파마슈티컬즈, 인코포레이티드 | 금속 효소 억제 화합물 |
| US9663491B2 (en) * | 2014-04-15 | 2017-05-30 | Dow Agrosciences Llc | Metalloenzyme inhibitor compounds as fungicides |
| US9944664B2 (en) * | 2014-04-15 | 2018-04-17 | Dow Agrosciences Llc | Metalloenzyme inhibitor compounds as fungicides |
| EP4311577A3 (en) * | 2016-12-29 | 2024-04-17 | Ji Xing Pharmaceuticals Hong Kong Limited | Metalloenzyme inhibitor compounds |
-
2013
- 2013-01-18 EA EA201491385A patent/EA026209B1/ru unknown
- 2013-01-18 DK DK13738427.7T patent/DK2804858T3/da active
- 2013-01-18 EP EP13738427.7A patent/EP2804858B1/en active Active
- 2013-01-18 AU AU2013209516A patent/AU2013209516A1/en not_active Abandoned
- 2013-01-18 CA CA2861339A patent/CA2861339C/en active Active
- 2013-01-18 US US14/373,314 patent/US10221160B2/en active Active
- 2013-01-18 IN IN6792DEN2014 patent/IN2014DN06792A/en unknown
- 2013-01-18 WO PCT/US2013/022313 patent/WO2013109998A1/en not_active Ceased
- 2013-01-18 KR KR1020147023020A patent/KR102061137B1/ko active Active
- 2013-01-18 JP JP2014553491A patent/JP6189865B2/ja active Active
- 2013-01-18 BR BR112014017751-1A patent/BR112014017751B1/pt active IP Right Grant
- 2013-01-18 CN CN201380010231.4A patent/CN104136427B/zh active Active
- 2013-01-18 PL PL13738427T patent/PL2804858T3/pl unknown
- 2013-01-18 ES ES13738427T patent/ES2774267T3/es active Active
-
2017
- 2017-09-20 AU AU2017232080A patent/AU2017232080B2/en active Active
-
2019
- 2019-01-28 US US16/259,096 patent/US10526312B2/en active Active
-
2020
- 2020-01-06 US US16/735,094 patent/US11247981B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015504095A5 (enExample) | ||
| JP2019502755A5 (enExample) | ||
| JP2015505841A5 (enExample) | ||
| US11247981B2 (en) | Metalloenzyme inhibitor compounds | |
| JP2016526535A5 (enExample) | ||
| Rani et al. | Imidazoles as potential antifungal agents: A review | |
| JP5266430B2 (ja) | 金属酵素阻害化合物 | |
| AR118840A2 (es) | Combinaciones de compuestos activos que comprenden un derivado de (tio)carboxamida y un compuesto fungicida | |
| JP2017528504A5 (enExample) | ||
| CA3052898A1 (en) | Composition for controlling harmful microorganisms comprising 1 -(phenoxy-pyridinyl)-2-(1,2,4-triazol-1 -yl)-ethanol derivatives | |
| JP6337896B2 (ja) | テトラゾリノン化合物及びその用途 | |
| CA2718383A1 (en) | Heteroaryl-substituted dicyanopyridines and use thereof for treatment of cardiovascular diseases | |
| JP2014501717A5 (enExample) | ||
| CA2915054A1 (en) | Metalloenzyme inhibitor compounds | |
| JP2015508749A5 (enExample) | ||
| JP6185056B2 (ja) | 殺菌・殺カビ性４−メチルアニリノピラゾール | |
| JP2011518178A5 (enExample) | ||
| JP2018021060A5 (enExample) | ||
| JP2015534940A (ja) | 植物病害防除剤、植物病害防除方法、および植物病害防除用製品 | |
| JP2019532107A (ja) | 望ましくない植物病原性微生物と戦うことで作物を保護するための４−アミノ置換フェニルアミジン誘導体およびその使用 | |
| JP4685761B2 (ja) | 植物保護剤としてのｎ−フェニル−‘（４−ピリジル）−アジニルアミン誘導体 | |
| CN114829357A (zh) | 五元杂环氧代羧酸类化合物及其医药用途 | |
| NZ602981A (en) | NOVEL ANTIFUNGAL 5,6-DIHYDRO-4-[(DIFLUOROETHYL)PHENYL]-4H-PYRROLO[1,2-a][1,4]BENZODIAZEPINE AND 4-(DIFLUOROETHYL)PHENYL-6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINE DERIVATIVES | |
| JP2018520104A5 (enExample) | ||
| JP2013507383A5 (enExample) |